David completed his degree in Chemical Engineering at Worcester Polytechnic Institute. He holds a Healthcare Finance certificate from MITx.
 

David began his career at Shire Pharmaceuticals working in manufacturing and then as a process development engineer. From there, he moved into life science consulting with Longfellow Associates where he led projects and at times managed a team of consultants. Later, David joined AptaTargets where he served as the company’s CBO responsible for the company’s partnering initiatives. Throughout his career David has supported and led many life science transactions with assets ranging across many indications and stages.
 

David joined AbilityPharma in July 2024 as the Chief Business Officer to lead partnering and support some of the company’s strategic initiatives.

• 

  Chief Business Officer (CBO) in Ability Pharma

  AbilityPharma is a clinical stage phase 2b biopharmaceutical company focused on autophagy to treat cancer